Mercado del cáncer colorrectal de América del Norte hasta 2027: análisis regional y pronósticos por modalidad (tipo de diagnóstico, tipo de terapia, tipo de imágenes); Usuario final (hospitales, laboratorios de diagnóstico e investigación) y país

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 157    |    Report Code: TIPRE00009241    |    Category: Life Sciences

North America Colorectal Cancer Market

Se espera que el mercado del cáncer colorrectal en América del Norte crezca de 8.559,27 millones de dólares estadounidenses en 2022 a 11.198,11 millones de dólares estadounidenses en 2028; se estima que crecerá a una tasa compuesta anual del 3,4 % entre 2022 y 2028.

 

El cáncer colorrectal es uno de los más Cánceres letales que se encuentran comúnmente en individuos con la influencia combinada de factores genéticos y ambientales. A una población importante de América del Norte se le diagnostica cáncer colorrectal. Según los Centros para el Control y la Prevención de Enfermedades (CDC) y la Sociedad Estadounidense del Cáncer, se estima que 1,93 millones de adultos en los EE. UU. fueron diagnosticados con cáncer de colon y recto, y 53,200 muertes fueron causadas por cáncer colorrectal en 2020. Estas estadísticas muestran una mayor demanda. para el diagnóstico y la terapia avanzados del cáncer en la región. Por lo tanto, la creciente prevalencia del cáncer colorrectal y el creciente número de pacientes diagnosticados con la enfermedad están impulsando el crecimiento del mercado del cáncer colorrectal en América del Norte.

 

Con las nuevas funciones y tecnologías, los proveedores pueden atraer nuevos clientes y ampliar su presencia en los mercados emergentes. Es probable que este factor impulse el mercado del cáncer colorrectal de América del Norte a una tasa compuesta anual sustancial durante el período de pronóstico.

 

 

Cáncer colorrectal de América del Norte

Ingresos del mercado y pronóstico hasta 2028 (millones de dólares estadounidenses)

Segmentación del mercado del cáncer colorrectal en América del Norte

 

El mercado del cáncer colorrectal en América del Norte está segmentado en modalidad, usuario final y país. Según la modalidad, el mercado del cáncer colorrectal de América del Norte se segmenta en tipo de diagnóstico, tipo de terapia y tipo de imágenes. En 2022, el segmento de tipo de diagnóstico tuvo la mayor participación de mercado y se espera que registre la CAGR más alta durante el período de pronóstico. Según el usuario final, el mercado del cáncer colorrectal de América del Norte se divide en hospitales y centros de diagnóstico y diagnóstico. laboratorios de investigación. En 2022, el segmento de hospitales tenía una mayor cuota de mercado. Según el país, el mercado del cáncer colorrectal de América del Norte está segmentado en EE. UU., Canadá y México. Estados Unidos tuvo la mayor cuota de mercado en 2022.

 

Abbott, Amgen Inc., Bruker Corporation, Clinical Genomics Technologies Pty Ltd., Epigenomics AG, F. Hoffmann-La Roche AG, Quest Diagnostics y VolitionRx Limited se encuentran entre las empresas líderes que operan en el mercado del cáncer colorrectal de América del Norte.  



North America Colorectal Cancer Strategic Insights

Strategic insights for North America Colorectal Cancer involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-colorectal-cancer-market-strategic-framework.webp
Get more information on this report

North America Colorectal Cancer Report Scope

Report Attribute Details
Market size in 2022 US$ 8,559.27 Million
Market Size by 2028 US$ 11,198.11 Million
Global CAGR (2022 - 2028) 3.4%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Modalidad
  • Tipo de diagnóstico
  • Tipo de terapia
  • Tipo de imagen
By Usuario final
  • hospitales
  • laboratorios de diagnóstico e investigación
Regions and Countries Covered América del Norte
  • EE. UU.
  • Canadá
  • México
Market leaders and key company profiles
  • Abbott
  • Amgen Inc.
  • Bruker Corporation
  • Clinical Genomics Technologies Pty Ltd.
  • Epigenomics AG
  • F. Hoffmann-La Roche AG
  • Quest Diagnostics
  • VolitionRx Limited
  • Get more information on this report

    North America Colorectal Cancer Regional Insights

    The regional scope of North America Colorectal Cancer refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-colorectal-cancer-market-geography.webp
    Get more information on this report

    The List of Companies - North America Colorectal Cancer Market

    1. Abbott
    2. Amgen Inc.
    3. Bruker Corporation
    4. Clinical Genomics Technologies Pty Ltd.
    5. Epigenomics AG
    6. F. Hoffmann-La Roche AG
    7. Quest Diagnostics  
    8. VolitionRx Limited
    Frequently Asked Questions
    How big is the North America Colorectal Cancer Market?

    The North America Colorectal Cancer Market is valued at US$ 8,559.27 Million in 2022, it is projected to reach US$ 11,198.11 Million by 2028.

    What is the CAGR for North America Colorectal Cancer Market by (2022 - 2028)?

    As per our report North America Colorectal Cancer Market, the market size is valued at US$ 8,559.27 Million in 2022, projecting it to reach US$ 11,198.11 Million by 2028. This translates to a CAGR of approximately 3.4% during the forecast period.

    What segments are covered in this report?

    The North America Colorectal Cancer Market report typically cover these key segments-

  • Modalidad (Tipo de diagnóstico, Tipo de terapia, Tipo de imagen)
  • Usuario final (hospitales, laboratorios de diagnóstico e investigación)
  • What is the historic period, base year, and forecast period taken for North America Colorectal Cancer Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Colorectal Cancer Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in North America Colorectal Cancer Market?

    The North America Colorectal Cancer Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott
  • Amgen Inc.
  • Bruker Corporation
  • Clinical Genomics Technologies Pty Ltd.
  • Epigenomics AG
  • F. Hoffmann-La Roche AG
  • Quest Diagnostics
  • VolitionRx Limited
  • Who should buy this report?

    The North America Colorectal Cancer Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Colorectal Cancer Market value chain can benefit from the information contained in a comprehensive market report.